EP1773803A1 - Verfahren zur synthese von 2,5-dioxane-1,4-dionen - Google Patents

Verfahren zur synthese von 2,5-dioxane-1,4-dionen

Info

Publication number
EP1773803A1
EP1773803A1 EP05793596A EP05793596A EP1773803A1 EP 1773803 A1 EP1773803 A1 EP 1773803A1 EP 05793596 A EP05793596 A EP 05793596A EP 05793596 A EP05793596 A EP 05793596A EP 1773803 A1 EP1773803 A1 EP 1773803A1
Authority
EP
European Patent Office
Prior art keywords
radical
process according
preparation process
oxidizing agent
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05793596A
Other languages
English (en)
French (fr)
Inventor
Didier Bourissou
Blanca Martin-Vaca
Frédéric Résidence du Parc de Lespinet BEN
Magalie Graullier
Roland Cherif-Cheikh
Martin Montes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of EP1773803A1 publication Critical patent/EP1773803A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/121,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Definitions

  • the present invention relates to a novel method for synthesizing 2,5-dioxane-1,4-diones.
  • PLGAs are generally obtained by ring-opening (co) polymerization of lactide and glycolide. These monomers derived from lactic acid and glycolic acid are the prototypes of 2,5-dioxane-1,4-diones.
  • the modification of PLGA properties is an important issue, particularly in their application as a biodegradable and bioassimilable matrix for entrapment and controlled release of active ingredients.
  • the approach of modifying the 2,5-dioxane-1,4-dione backbone substituents has been poorly developed so far, which can be explained in practice by low-potency. accessibility of these patterns.
  • Symmetrical monomers such as lactide or glycolide are generally prepared from the corresponding ⁇ -hydroxy acids. This approach is difficult because it requires the elimination of the water formed and the vacuum distillation of the monomer.
  • two different precursors must be used, typically an ⁇ -hydroxy acid and a mono- or dihalogenated derivative (CM Dong et al., Polym. ScI Part A: Polym. Chern. 4179-4184, M. Leemhuis et al, EUT J. Org Chem 2003, 3344-3349).
  • the subject of the present invention is therefore a process for the preparation of 2,5-dioxane-1,4-diones of formula (I)
  • R 1 , R 2 , R 3 and R 4 represent, independently, the hydrogen atom; halo; (C 2 -C 6 ) alkenyl; (C 3 -C 7 ) cycloalkyl; cyclohexenyl; a radical of formula - (CH 2 VV-W
  • V represents a covalent bond, the oxygen atom or the radical -C (O) -O-;
  • W represents the hydrogen atom, a (C 1 -C 18) alkyl radical optionally substituted with one or more identical or different halo radicals; the aryl or aralkyl radical, the aryl and aralkyl radicals being optionally substituted with one or more identical or different substituents chosen from: - (CH 2 ) n -YZ, halo, nitro and cyano;
  • Y represents -O-, -S- or a covalent bond
  • Z represents the hydrogen atom or a radical optionally substituted with one or more identical or different halo radicals; or aralkyl;
  • n and n independently represent an integer of 0 to 4.
  • halo represents the fluoro, chloro, bromo or iodo radical, preferably chloro, fluoro or bromo.
  • the term (CrC 6 ) alkyl represents an alkyl radical having 1 to 6 carbon atoms, linear or branched, such as the methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl, pentyl radicals. or amyl, isopentyl, neopentyl, 2,2-dimethylpropyl, hexyl, isohexyl or 1,2,2-trimethylpropyl.
  • (CrC 18 ) alkyl denotes an alkyl radical having from 1 to 18 carbon atoms, linear or branched, such radicals containing from 1 to 6 carbon atoms as defined above but also heptyl, octyl, 1,1 , 2,2-tetramethyl-propyl, 1,1,3,3-tetramethyl-butyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl.
  • alkyl substituted with at least one halo radical it is necessary to understand any linear or branched alkyl chain containing at least one halo radical positioned along the chain such as for example -CHCl-CH 3 but also -CF 3 .
  • the radical (CH 2 ) I (integer may represent m and n as defined above), represents a hydrocarbon chain, linear or branched, of i carbon atoms.
  • the radical - (CH 2 ) 3 - can represent -CH 2 -CH 2 -CH 2 - but also -CH (CH 3 ) -CH 2 -, -CH 2 -CH (CH 3 ) - or -C (CH 3 ) 2 -.
  • (C 2 -C 6 ) alkenyl is meant a linear or branched alkyl radical having from 2 to 6 carbon atoms and having at least one unsaturation (double bond), for example vinyl, allyl, propenyl, butenyl or pentenyl.
  • cycloalkyl denotes a saturated carbon monocyclic system comprising from 3 to 7 carbon atoms, and preferably the cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl rings.
  • aryl represents an aromatic radical, consisting of a ring or condensed rings, such as, for example, the phenyl, naphthyl, fluorenyl or anthryl radical.
  • aralkyl preferably refers to radicals in which the radicals aryl and alkyl are as defined above such as benzyl or phenethyl.
  • oxidation For the conversion of the ketone function of the compound (II) to ester function, several types of oxidation can be used; the oxidation can thus be carried out for example in the presence of an oxidizing agent such as a peracid or a peroxide (according to the oxidation reaction of Baeyer Villiger), in the presence of a metal catalyst (SI Murahashi et al, Tetrahedron Lett, 1992, 33, 7557-7760 and C. BoIm et al., Tetrahedron Lett., 1993, 34, 3405-3408) or enzymatically (MD Mihovilovic et al, EW J. Org Chem 2002, 3711 -3730).
  • an oxidizing agent such as a peracid or a peroxide (according to the oxidation reaction of Baeyer Villiger)
  • a metal catalyst SI Murahashi et al, Tetrahedron Lett, 1992, 33, 7557-7760 and C.
  • a process according to the invention is carried out in the presence of an oxidizing agent according to the oxidation reaction of Baeyer Villiger.
  • the oxidation reaction is very preferably carried out on the most congested side of the ketone so that 2,5-dioxane-1,4-diones can be obtained very selectively.
  • the oxidizing agent is used in the presence of a catalyst.
  • the oxidizing agent (or oxidation agent) used for carrying out the process according to the invention may be a peracid or a peroxide.
  • a peracid mention may be made of trifluoroperacetic acid (TFPAA), peracetic acid (PAA) and metachloroperbenzoic acid (m-CPBA), preferably in combination with
  • peroxide As an example of peroxide, mention may be made of hydrogen peroxide (H 2 O 2 ); the hydrogen peroxide will be used alone or in the presence of a catalyst which may be a Lewis acid (such as BF 3 ) or a metal complex whether in a homogeneous phase (Mo,
  • the present invention more particularly relates to a process as defined above, characterized in that the oxidizing agent is a peracid or a peroxide.
  • the oxidizing agent is a peracid.
  • the peracid is preferably used in the presence of a Lewis acid or a strong acid, and more particularly in the presence of a strong acid chosen from sulphonic acids.
  • the peracid is metachloroperbenzoic acid (m-CPBA).
  • Metachloroperbenzoic acid is preferably used in the presence of trifluoromethanesulfonic acid.
  • the oxidizing agent is a peroxide.
  • oxidation agents mentioned above are in general commercial. Non-commercial agents may be synthesized according to methods known to those skilled in the art. Thus, trifluoroperacetic acid which is not commercially available can easily be obtained by the action of hydrogen peroxide H 2 O 2 on trifluoroacetic acid or trifluoroacetic anhydride CF 3 CO 2 H and (CF 3 CO) 2 O, respectively (Liotta, R., et al., J. Org Chem 1980, 45, 2887-2890, M. Anastasia et al., J. Org Chem 1985, 50, 321-325, PA Krasutsky et al., J. Org. Chem 2001, 66, 1701-1707).
  • bis (trimethylsilyl) peroxide is not commercially available but is easily accessible from the complex H 2 O 2 - 1,4-diazabicyclo [2,2,2] octane [DABCO, N (CH 2 CH 2 3 N] and Me 3 SiCl (PG Cookson et al., J Orga.nomet.Chem, 1975, 99, C31-C32, M. Taddei et al., Synth.Comm., 1986, 633-635).
  • Cyclic keto esters of formula (II), used as precursors for the synthesis of 2,5-dioxane-1,4-diones (I) as defined above, are easily accessible by conventional methods known to the art. those skilled in the art (EB Reid et al, J. Org Chem 1950, 15, 572-582).
  • the present invention more particularly relates to a process as defined above, characterized in that the aryl radical is the phenyl radical and the aralkyl radical is the benzyl radical.
  • the present invention more particularly relates to a process as defined above, characterized in that R 1, R 2 , R 3 and R 4 represent, independently, the hydrogen atom; or a radical of formula - (CH 2 ) m -VW with V which represents a covalent bond and W a (C 1 -C 6 ) alkyl radical, and more preferably m is equal to zero.
  • R 1 , R 2 , R 3 and R 4 represent, independently, the hydrogen atom, the methyl radical or the ethyl radical.
  • the present invention more particularly relates to a process as defined above, characterized in that R 1 and R 2 represent, independently, a radical of formula - (CH 2 ) m -VW with V which represents a covalent bond, m is zero and W is (C 1 -C 6 ) alkyl, and R 3 and R 4 are, independently, hydrogen or a radical of formula - (CH 2 ) H iVW with V which represents a covalent bond, m is zero and W a (C 1 -C 6 ) alkyl radical.
  • the present invention more particularly relates to a process as defined above, characterized in that R 1 and R 2 represent, independently, the methyl or ethyl radical, and R 3 and R 4 represent, independently, the atom hydrogen or a methyl or ethyl radical.
  • the subject of the present invention is also compounds of formula (I) as obtained according to the process defined above.
  • Step 1 synthesis of the precursor (II)
  • the formation of the compound (2) from the compound (1) can be carried out according to H. C. Brown et al., J. Am. Chern. Soc. 1988, 110, 1539-1546.
  • the synthesis steps of the compounds (3) and (4) can be carried out according to M. Conrad et al., Ber.
  • the final step of forming the compound (II) from the compound (4) can be carried out according to E.B. Reid et al., J. Org. Chem. 1950, 75, 572-582.
  • Step 2 synthesis of 3,3-dimethyl-2,5-dioxane-1,4-dione
  • Step 1 synthesis of the precursor (II)
  • the exponent of the anisotropic displacement factor takes the form: -2 ⁇ 2 [h 2 a * 2 U n + ... + 2 hka * b * U 12 ]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
EP05793596A 2004-07-26 2005-07-25 Verfahren zur synthese von 2,5-dioxane-1,4-dionen Withdrawn EP1773803A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0408211A FR2873371B1 (fr) 2004-07-26 2004-07-26 Nouvelle methode de synthese de 2,5 dioxane 1,4 diones
PCT/FR2005/001909 WO2006018524A1 (fr) 2004-07-26 2005-07-25 Methode de synthese de 2,5-dioxane-1,4-diones

Publications (1)

Publication Number Publication Date
EP1773803A1 true EP1773803A1 (de) 2007-04-18

Family

ID=34947240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05793596A Withdrawn EP1773803A1 (de) 2004-07-26 2005-07-25 Verfahren zur synthese von 2,5-dioxane-1,4-dionen

Country Status (6)

Country Link
US (1) US7504524B2 (de)
EP (1) EP1773803A1 (de)
AR (1) AR049740A1 (de)
FR (1) FR2873371B1 (de)
RU (1) RU2382774C2 (de)
WO (1) WO2006018524A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873371B1 (fr) 2004-07-26 2008-07-04 Sod Conseils Rech Applic Nouvelle methode de synthese de 2,5 dioxane 1,4 diones
WO2012008830A1 (en) * 2010-07-13 2012-01-19 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Methods and compositions for deacidifying fruit juice
ITMI20131300A1 (it) * 2013-08-01 2015-02-02 Nobil Bio Ricerche Srl Composizione per il riempimento di difetti ossei e parodontali
US20220354783A1 (en) 2018-08-01 2022-11-10 Edix-O Sarl Injectable prolonged-action compositions for use in the treatment of nail disease and/or for promoting nail growth
EP3603650A1 (de) 2018-08-01 2020-02-05 Edix O Sarl Injizierbare zusammensetzungen mit langzeitwirkung zur verwendung in der behandlung von nagelkrankheiten und/oder zur beschleunigung des nagelwachstums
IT202000014575A1 (it) 2020-06-18 2021-12-18 Pnd Costr Elettromeccaniche S R L Macchina per la lavorazione dell'avocado.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1052046A (en) * 1974-01-21 1979-04-03 American Cyanamid Company Unsymmetrically substituted 1,4-dioxane-2,5-diones
US5326887A (en) * 1991-02-27 1994-07-05 E. I. Du Pont De Nemours And Company Process for the preparation of 1,4-dioxane-2,5-diones
DE10000333A1 (de) * 2000-01-07 2001-07-19 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur transdermalen Verabreichung von Hormonen mit einem permeationsverbessernden Zusatzstoff
FR2873371B1 (fr) 2004-07-26 2008-07-04 Sod Conseils Rech Applic Nouvelle methode de synthese de 2,5 dioxane 1,4 diones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006018524A1 *

Also Published As

Publication number Publication date
US20080004453A1 (en) 2008-01-03
WO2006018524A1 (fr) 2006-02-23
FR2873371B1 (fr) 2008-07-04
AR049740A1 (es) 2006-08-30
FR2873371A1 (fr) 2006-01-27
US7504524B2 (en) 2009-03-17
RU2007106842A (ru) 2008-09-10
RU2382774C2 (ru) 2010-02-27

Similar Documents

Publication Publication Date Title
EP1773803A1 (de) Verfahren zur synthese von 2,5-dioxane-1,4-dionen
CA2295874C (fr) Complexes metalliques avec un ligand tridentate comme catalyseurs de polymerisation
EP1027357B1 (de) Neue verbindungen, die ein element der gruppe 13 enthalten, das mit einem mono- oder dianionischen dreizähnigen liganden gebunden ist, ein verfahren zu ihrer herstellung und ihre anwendung als polymerisationskatalysatoren
EP1196422B1 (de) Polymerisationskatalysatoren
CA2342990A1 (fr) Derives de l'artemisinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1999042211A1 (fr) Catalyseur d'oxydation et procede d'oxydation via ce catalyseur
CA2559570A1 (fr) Utilisation d'un systeme catalytique pour la (co)oligomerisation du lactide et du glycolide
EP1392752B1 (de) Verwendung von zinkderivaten als polymerisationskatalysatoren von cyclischen estern
EP1981861A2 (de) Neues verfahren zur synthese von 1,4-morpholin-2,5-dionen
EP1218366B8 (de) Verfahren zur herstellung von cox-2 inhibitoren
CA2377180C (fr) Catalyseurs de polymerisation
EP0270468B1 (de) Verfahren zur Herstellung einer Cyclohexanol und Cyclohexanon enthaltenden Mischung aus Cyclohexan
Chow et al. Total synthesis of 13-oxygenated prostanoids derived from arachidonate: an instance of extraordinary variability in the stereochemical sense of a Mukaiyama aldol reaction
FR2525224A1 (fr) Nouveaux complexes de metaux de transition coordones avec un acide de lewis, procede de preparation de ces complexes, utilisation de ces complexes en tant que catalyseurs dans la reaction de metathese des olefines
CH618423A5 (de)
EP1290062B1 (de) Verwendung von stannylenen und germylenen als polymerisationskatalysatoren für heterocyclen
WO2023156461A1 (fr) Procede de preparation de composes comportant une structure 2,5-dihydrobenzoxepine par rearrangement photochimique
FR3094368A1 (fr) Procédé de préparation de composés 1,2-endoperoxyde
WO2024052250A1 (fr) Procédé de préparation d'alcénylaminoboranes avec ou sans catalyseur, et de leurs dérivés, et leurs utilisations
FR2826595A1 (fr) Catalyseurs organometalliques, et leur utilisation pour realiser des oxydations d'olefines et des oxydations de sulfures en sulfoxydes
CH616138A5 (en) Process for the preparation of ketones containing a secondary or tertiary aliphatic carbon atom in at least one of the positions alpha to the carbonyl group
WO2009150318A1 (fr) Nouveaux derives de quinoleines 2-substituees et un procede pour leur preparation
WO2013041807A1 (fr) Nouveaux composes tricycliques, leur procede de preparation, et leurs utilisations

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070226

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CHERIF-CHEIKH, ROLAND

Inventor name: BEN, FREDERIC,MAISON HARDOY

Inventor name: MONTES, MARTIN

Inventor name: GRAULLIER, MAGALIE

Inventor name: MARTIN-VACA, BLANCA

Inventor name: BOURISSOU, DIDIER

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080306

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: IPSEN PHARMA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110907